153 related articles for article (PubMed ID: 31237218)
21. Disturbances of modulating molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA expressions in the orbital tissue from patients with severe graves' ophthalmopathy.
Pawlowski P; Wawrusiewicz-Kurylonek N; Eckstein A; Reszec J; Luczynski W; Johnson K; Kretowski A; Bakunowicz-Lazarczyk A; Gorska M; Szamatowicz J; Chyczewski L; Mysliwiec J
Mediators Inflamm; 2015; 2015():340934. PubMed ID: 25653477
[TBL] [Abstract][Full Text] [Related]
22. A Mechanism Study of Electroacupuncture for Dry Eye Syndrome by Targeting Conjunctival Cytokine Expressions.
Zhang D; Zhao Y; Yang YT; Zhao Y; Wu DY; Liu XX; Shi Z; Hong J; Liu J; Ma XP
Curr Eye Res; 2020 Apr; 45(4):419-427. PubMed ID: 31557061
[No Abstract] [Full Text] [Related]
23. Smoking induces overexpression of immediate early genes in active Graves' ophthalmopathy.
Planck T; Shahida B; Parikh H; Ström K; Åsman P; Brorson H; Hallengren B; Lantz M
Thyroid; 2014 Oct; 24(10):1524-32. PubMed ID: 25135760
[TBL] [Abstract][Full Text] [Related]
24. Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy.
Kishazi E; Dor M; Eperon S; Oberic A; Turck N; Hamedani M
Sci Rep; 2018 Jul; 8(1):10792. PubMed ID: 30018377
[TBL] [Abstract][Full Text] [Related]
25. [Role of Treg/Th17 cells and related cytokines in Graves' ophthalmopathy].
Lv M; Shen J; Li Z; Zhao D; Chen Z; Wan H; Hao B
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1809-13. PubMed ID: 25537908
[TBL] [Abstract][Full Text] [Related]
26. Tears as a Source of Biomarkers in the Diagnosis of Graves' Orbitopathy.
Bajkowska D; Szelachowska M; Buczyńska A; Krętowski AJ; Siewko K
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358969
[TBL] [Abstract][Full Text] [Related]
27. Histamine induces NF-κB controlled cytokine secretion by orbital fibroblasts via histamine receptor type-1.
Virakul S; Phetsuksiri T; van Holten-Neelen C; Schrijver B; van Steensel L; Dalm VASH; Paridaens D; van den Bosch WA; van Hagen PM; Dik WA
Exp Eye Res; 2016 Jun; 147():85-93. PubMed ID: 27170049
[TBL] [Abstract][Full Text] [Related]
28. Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist.
Khalilzadeh O; Anvari M; Esteghamati A; Mahmoudi M; Tahvildari M; Rashidi A; Khosravi F; Amirzargar A
Clin Exp Ophthalmol; 2009 Aug; 37(6):614-9. PubMed ID: 19702713
[TBL] [Abstract][Full Text] [Related]
29. Molecular biomarkers of Graves' ophthalmopathy.
Longo CM; Higgins PJ
Exp Mol Pathol; 2019 Feb; 106():1-6. PubMed ID: 30414981
[TBL] [Abstract][Full Text] [Related]
30. CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy.
Wang H; Zhu LS; Cheng JW; Cai JP; Li Y; Ma XY; Wei RL
Graefes Arch Clin Exp Ophthalmol; 2015 Apr; 253(4):573-82. PubMed ID: 25576172
[TBL] [Abstract][Full Text] [Related]
31. Serum pro- and anti-inflammatory cytokines in patients with Graves' disease with ophthalmopathy during treatment with glucocorticoids.
Myśliwiec J; Kretowski A; Szelachowska M; Mikita A; Kinalska I
Rocz Akad Med Bialymst; 1999; 44():160-9. PubMed ID: 10697431
[TBL] [Abstract][Full Text] [Related]
32. Research on the Potential Mechanism of Gypenosides on Treating Thyroid-Associated Ophthalmopathy Based on Network Pharmacology.
Li K; Li H; Xu W; Liu W; Du Y; He JF; Ma C
Med Sci Monit; 2019 Jul; 25():4923-4932. PubMed ID: 31268042
[TBL] [Abstract][Full Text] [Related]
33. Research progress in Th17 cells and the relevant cytokines in Graves
Jiang M; Zhao J; Wang P; Yan S; Wang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1748-1753. PubMed ID: 36748387
[TBL] [Abstract][Full Text] [Related]
34. Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy.
Myśliwiec J; Waligórski D; Nikołajuk A; Górska M
Adv Med Sci; 2007; 52():104-8. PubMed ID: 18217399
[TBL] [Abstract][Full Text] [Related]
35. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
[TBL] [Abstract][Full Text] [Related]
36. Altered tear composition in smokers and patients with graves ophthalmopathy.
Baker GR; Morton M; Rajapaska RS; Bullock M; Gullu S; Mazzi B; Ludgate M
Arch Ophthalmol; 2006 Oct; 124(10):1451-6. PubMed ID: 17030713
[TBL] [Abstract][Full Text] [Related]
37. Interaction Between CCR6+ Th17 Cells and CD34+ Fibrocytes Promotes Inflammation: Implications in Graves' Orbitopathy in Chinese Population.
Fang S; Huang Y; Liu X; Zhong S; Wang N; Zhao B; Li Y; Sun J; Wang Y; Zhang S; Gu P; Zhou H; Li B; Fan X
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2604-2614. PubMed ID: 29847667
[TBL] [Abstract][Full Text] [Related]
38. Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.
Feldon SE; Park DJ; O'Loughlin CW; Nguyen VT; Landskroner-Eiger S; Chang D; Thatcher TH; Phipps RP
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3913-21. PubMed ID: 16249464
[TBL] [Abstract][Full Text] [Related]
39. Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves' ophthalmopathy.
Wei H; Guan M; Qin Y; Xie C; Fu X; Gao F; Xue Y
Endocr J; 2014; 61(11):1087-92. PubMed ID: 25100151
[TBL] [Abstract][Full Text] [Related]
40. Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves' Disease.
Zhao J; Lin B; Deng H; Zhi X; Li Y; Liu Y; Bible PW; Li Q; Xu B; Wei L; Yang H; Huang D
Curr Mol Med; 2018; 18(2):83-90. PubMed ID: 29974826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
